Themis Medicare Share News - Latest Updates, Live News & More

Latest news about Themis Medicare

Themis Medicare Opens Special Window for Physical Share Transfer and Dematerialization 2 days ago

Themis Medicare Limited has opened a special one-year window from February 05, 2026 to February 04, 2027 for shareholders to re-lodge transfer requests and dematerialize physical shares, following SEBI Circular dated January 30, 2026. The facility targets shareholders who had transactions prior to April 01, 2019 but faced transfer process challenges, with transferred shares subject to mandatory Demat mode and one-year lock-in period.

Themis Medicare Limited Announces Postal Ballot Results with All Four Resolutions Approved Mar 28, 2026

Vividhmargi Investments Increases Stake in Themis Medicare to 26.52% Through Amalgamation Mar 28, 2026

Themis Medicare receives tax demand notice of ₹13.32 crore from Income Tax Department Mar 27, 2026

Themis Medicare Committee Formally Approves Warrant Price Revision to Rs. 102.87 Mar 11, 2026

More news about Themis Medicare

25Feb 26

Themis Medicare Approves Preferential Issue of 45,95,795 Convertible Equity Warrants at Rs. 100 Each

Themis Medicare Limited's Preferential Issue Committee approved the allotment of 45,95,795 convertible equity warrants to Vividhmargi Investments Private Limited at Rs. 100 per warrant on February 25, 2026. The issue price was rounded up from the minimum price of Rs. 99.76 as certified by practicing company secretary Mr. Abhishek Wagh. The company has scheduled a postal ballot from February 26 to March 27, 2026, to obtain shareholder approval for this preferential issue, which also requires stock exchange approval.

14Feb 26

Themis Medicare Limited Announces Resignation of Company Secretary and Compliance Officer

Themis Medicare Limited announced the resignation of Mr. Pradeep M. Chandan from his roles as Company Secretary, Compliance Officer, and Key Managerial Personnel, effective February 13, 2026. The resignation was attributed to other professional commitments, and the company has duly informed BSE and NSE about this management change under Regulation 30 compliance requirements.

11Dec 25

Themis Medicare Allots 60,000 Equity Shares Under Employee Stock Option Scheme

Themis Medicare Limited allotted 60,000 equity shares under its Employee Stock Option Scheme 2012 on December 11, 2025, following approval by the Allotment Committee. The shares, with a face value of ₹1.00 each, were issued to eligible employees upon exercise of vested options. This allotment increased the company's paid-up equity share capital from 9,20,40,120 to 9,21,00,120 shares. The newly issued shares rank pari-passu with existing equity shares and the company has completed all required regulatory disclosures with BSE and NSE.

13Nov 25

Themis Medicare Reports Loss in Q2 FY2026, Withdraws Merger with Gujarat Themis Biosyn

Themis Medicare Limited reported a net loss of Rs. 635.55 lakhs in Q2 FY2026, compared to a profit of Rs. 1,337.25 lakhs in Q2 FY2025. Revenue from operations decreased to Rs. 7,799.41 lakhs from Rs. 11,700.99 lakhs. The company withdrew from a proposed merger with Gujarat Themis Biosyn Limited and received approval to strike off its UK subsidiary, Carpo Medicals Limited. Themis Medicare will focus on its domestic pharmaceutical formulations business.

12Sept 25

Themis Medicare Declares Dividend, Appoints New Independent Director and Secretarial Auditor

Themis Medicare announced key decisions at its 55th AGM. The company declared a dividend of Rs 0.50 per share, appointed Ms. Neha Thakore as an Independent Woman Director for a five-year term, and selected M/s. SAV & Associates LLP as Secretarial Auditor. Shareholders approved financial statements, re-appointed Dr. Adam Demeter as director, ratified Cost Auditor remuneration, and approved commission for Non-Executive Directors.

04Aug 25

Themis Medicare Reports Q1 Net Loss of 142 Million Rupees Amid Revenue Decline

Themis Medicare, a pharmaceutical company, reported a consolidated net loss of ₹142.00 million in Q1, contrasting with a ₹247.00 million profit in the same quarter last year. Revenue decreased by 24.92% to ₹976.00 million from ₹1,300.00 million. EBITDA turned negative at ₹101.00 million loss, compared to a positive ₹292.00 million in the previous year's quarter.

20May 25

Themis Medicare Reports Q4 Revenue Decline and Net Loss

Themis Medicare's Q4 financial results show a significant downturn. The company reported a net loss of ₹96.60 million, contrasting with a profit of ₹66.40 million in the same quarter last year. Revenue decreased by 26.70% compared to the previous quarter. This marks a notable shift from the ₹5.20 million profit in the preceding quarter, indicating volatility in the company's financial performance.